Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 9;11(12):e0167762.
doi: 10.1371/journal.pone.0167762. eCollection 2016.

Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015

Affiliations

Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015

Zuzana Jandova et al. PLoS One. .

Abstract

Background: This study presents antigenic and genetic characteristics of Neisseria meningitidis strains recovered from invasive meningococcal disease (IMD) in the Czech Republic in 1971-2015.

Material and methods: A total of 1970 isolates from IMD, referred to the National Reference Laboratory for Meningococcal Infections in 1971-2015, were studied. All isolates were identified and characterized by conventional biochemical and serological tests. Most isolates (82.5%) were characterized by multilocus sequence typing method.

Results: In the study period 1971-2015, the leading serogroup was B (52.4%), most often assigned to clonal complexes cc32, cc41/44, cc18, and cc269. A significant percentage of strains were of serogroup C (41.4%), with high clonal homogeneity due to hyperinvasive complex cc11, which played an important role in IMD in the Czech Republic in the mid-1990s. Serogroup Y isolates, mostly assigned to cc23, and isolates of clonally homogeneous serogroup W have also been recovered more often over the last years.

Conclusion: The incidence of IMD and distribution of serogroups and clonal complexes of N. meningitidis in the Czech Republic varied over time, as can be seen from the long-term monitoring, including molecular surveillance data. Data from the conventional and molecular IMD surveillance are helpful in refining the antimeningococcal vaccination strategy in the Czech Republic.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Incidence of invasive meningococcal disease, Czech Republic, 1943–2015.
Blue line is incidence (cases per 100 000 population) and the red line is surveillance since 1993.
Fig 2
Fig 2. Number of isolates of N. meningitidis from invasive meningococcal disease, Czech Republic, 1971–2015, n = 1970.
Fig 3
Fig 3. Annual distribution of serogroups of N. meningitidis from invasive meningococcal disease, Czech republic, 1971–2015, n = 1970 (NG = non groupable, nd = not defined).
Fig 4
Fig 4. Annual distribution of major clonal complexes of N. meningitidis from invasive meningococcal disease, Czech Republic, 1971–2015, n = 1970 (cc = clonal complex, ccUA = unassigned clonal complex, nd = not defined).
Fig 5
Fig 5. Annual distribution of major clonal complexes of N. meningitidis B from invasive meningococcal disease, Czech Republic, 1971–2015, n = 938 (cc = clonal complex, ccUA = unassigned clonal complex, nd = not defined).
Fig 6
Fig 6. Annual distribution of major clonal complexes of N. meningitidis C from invasive meningococcal disease, Czech Republic, 1971–2015, n = 741 (cc = clonal complex, ccUA = unassigned clonal complex, nd = not defined).

Similar articles

Cited by

References

    1. Vogel U, Frosch M (1999) Mechanisms of neisserial serum resistance. Mol Microbiol 32: 1133–1139. - PubMed
    1. Pollard AJ (2004) Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J 23: S274–279. - PubMed
    1. Caugant DA, Kristiansen PA, Wang X, Mayer LW, Taha MK, Ouédraogo R, et al. (2012) Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine. PLoS One 7: e46019 10.1371/journal.pone.0046019 - DOI - PMC - PubMed
    1. Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, et al. (2012) The changing and dynamic epidemiology of meningococcal disease. Vaccine 30 Suppl 2: B26–36. - PubMed
    1. Harrison LH, Trotter CL, Ramsay ME (2009) Global epidemiology of meningococcal disease. Vaccine 27 Suppl 2: B51–63. - PubMed

MeSH terms